Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM)

Historical Holders from Q3 2022 to Q3 2025

Symbol
ITRM on Nasdaq
CUSIP
G6333L200
Type / Class
Equity / Ordinary Shares, $0.01 par value per share
Shares outstanding
29M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
1.14M
Holdings value
$760K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
17
Number of buys
6
Number of sells
-11
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 4.99% $1.6M 1.45M Armistice Capital, LLC Dec 31, 2024

Institutional Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.14M $760K -$1.03M $0.67 17
2025 Q2 2.28M $2.27M +$1.24M $1.00 18
2025 Q1 1.03M $1.26M -$170K $1.23 16
2024 Q4 1.17M $2.07M -$600K $1.77 19
2024 Q3 2.04M $2.22M +$1.75M $1.09 15
2024 Q2 432K $495K -$755K $1.14 14
2024 Q1 929K $1.43M +$823K $1.54 15
2023 Q4 387K $761K +$151K $1.97 14
2023 Q3 130K $106K -$165K $0.81 10
2023 Q2 367K $393K +$195K $1.07 13
2023 Q1 187K $187K -$86.7K $1.00 15
2022 Q4 289K $243K +$35.1K $0.84 16
2022 Q3 206K $332K +$332K $1.61 12